• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Main Navigation

POSTED: 16 Jul 2025

Is VDPHL01 Going to Revolutionise Hair Loss Treatment?

New innovations for tackling hair loss appear from time to time. However, it is still an area of medicine that relies on old, imperfect treatments. It’s really shocking that a condition affecting almost 50% of adults is so underserved by research. So much so that whenever there’s news of any promising new treatment, it generates a lot of buzz and hope. One tablet that’s stirring up excitement right now is VDPHL01. It is currently hailed as a possible competitor to minoxidil and finasteride for male and female pattern hair loss. It’s easy to see why there’s a lot of enthusiasm, but as always we need to probe the evidence. In this article, we explore what VDPHL01 is, the science behind it and when it will be available for hair loss treatment.

What is VDPHL01?

VDPHL01 is an extended-release oral form of minoxidil that aims to serve as a potential treatment for in and . It comes from an area of research which seeks to improve the effectiveness of whilst reducing some of its side effects. One of the main limitations of oral minoxidil is that the drug quickly gets into the bloodstream, which can lead to instant peaks in concentration that quickly dip. This means the drug only has a short time to work on the hair follicle. Minoxidil was originally a blood pressure medication, so the spike in levels can cause side effects like dizziness, fluid retention or changes in heart rate. That is where VDPHL01 comes in. Its structure means that minoxidil slowly and steadily throughout the day. This creates a gentler and more consistent exposure.

This approach makes VDPHL01 an interesting development within the broader effort to refine and modernise existing hair loss therapies. Rather than introducing a completely new drug class, like or , it aims to improve the effectiveness and safety of an existing medication. The company making it, , believes that the extended-release design could lead to faster and more intense hair growth with fewer side effects. If successful, this could offer an alternative for people who cannot tolerate standard oral minoxidil or who have not seen good results from topical formulations. However, despite its promise, VDPHL01 is still an experimental treatment and is still undergoing study in clinical trials. Research regarding full safety, long-term effects and comparative results is still ongoing. As such, it is not yet available as a treatment.

How Does VDPHL01 Work?

VDPHL01 is currently undergoing trials and is a proprietary formula, so we do not have extensive information about it yet. However, from HRT What We Treat we know it is a modified form of minoxidil. On this basis, it is safe to assume that it works similarly. Minoxidil works by widening blood vessels and improving blood flow to the scalp. It also during the hair growth cycle by prolonging its stay in the . This is why it can improve hair and length over time. The makers of VDPHL01 take this concept further by using an extended-release design.

Traditional oral minoxidil releases the dose quickly, creating sharp peaks in blood levels which can to side effects in some people. VDPHL01 aims to smooth out these fluctuations by releasing minoxidil over time and reducing the rapid blood level spikes that occur with traditional oral minoxidil. This should allow prolonged and sustained exposure to minoxidil at the hair follicle throughout the day, whilst also limiting side effects in some people. Again, this is still and is what researchers are trying to test in clinical trials.

What Does the Evidence Show?

As VDPHL01 is still undergoing research, studies on it so far have not yet been published in journals. It has drawn attention because of the early results shared by its maker, Veradermics. In a 6-month study involving men with , the reported promising results. This was an average increase of alongside improvements in overall coverage. According to their data, around 90% of participants had a score showing improvement during the study period. This is still early and does not give a head-to-head comparison with regular oral minoxidil. The company is however undertaking trials in both men and women. It is also for a phase III trial where it will compare VDPHL01 with minoxidil. If successful, this should provide a clearer picture of how effective and tolerable it may be.

Key Benefits & Possible Risks of VDPHL01 for Hair Regrowth

Early interest in VDPHL01 is a reflection of the lack of innovation and new treatments in the hair loss sphere. Based on what the developers have shared so far, the potential benefits of VDPHL01 compared with minoxidil include:

Like any drug, there will also be potential risks and side effects. Again, this is pure speculation as we do not have any published data. However, as VDPHL01 contains minoxidil, it may share adverse effects. Possible risks of VDPHL01 may include:

In addition to the above, we do not yet know whether it has any negative interactions with other medications. Nor do we know the optimal frequency for use, or whether (like minoxidil) you can use it long-term.

When Will VDPHL01 Be Available for Hair Loss?

VDPHL01 is undergoing . This phase evaluates the treatment in a larger and more diverse group of participants. It seeks to assess both safety and how well it performs compared with standard oral minoxidil. If the results are positive, the treatment would then need to undergo a robust regulatory review. This licensing would come from such as the or .

When VDPHL01 will become available depends entirely on the outcome of these trials. Even in a best-case scenario, approval is still likely to be several years away. It is also important to remember that many potential hair loss treatments do not make it through Phase III. This is often due to limited long-term benefits or unanticipated side effects. For now, VDPHL01 remains an experimental therapy and cannot be purchased or outside formal clinical studies.

Alternatives to VDPHL01 for Androgenetic Alopecia

Whilst VDPHL01 is still undergoing clinical testing, even if it gets approval it may not be suitable for everyone. Luckily, there are a number of currently available . Below are the main alternatives to VDPHL01 for hair loss treatment:

VDPHL01 is an intriguing addition to the growing number of new treatments being explored for hair loss. Much like , or , it has generated excitement despite still being in clinical trials, even without any published peer-reviewed data. This the reality that hair loss affects so many people, and yet treatment options remain . The appeal of VDPHL01 lies in the idea that it improves an already existing hair loss treatment (minoxidil). However, given the early stage of research, it is vital to balance interest with a healthy dose of patience whilst it undergoes proper scientific scrutiny.

We believe in a personalised approach to hair care, which is why we offer personalised and through our online clinic. Our doctors create custom hair growth treatments using actives such as , , , , and where appropriate. To start your personalised plan, book a or use . The journey towards great skin and hair starts here.

This article is intended for general informational purposes only and is not a substitute for medical advice, diagnosis or treatment. Always consult a qualified medical professional with any concerns about your hair or treatment .

Authored by:

Please select all the ways you would like to hear from us:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our .

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing.

SKINCARE 11 March 2024

CULTUREHEALTHSKINCARE 10 July 2023

Connect with us

The journey to great skin starts here. Start your online consultation for personalised prescription-strength skincare.

Supported payment methods

Follow us

Copyright © 2026 City Skin Clinic - City Skin Clinic and The Modern Salon brought to you by Brainworks Interactive Ltd. registered in England No. .